PETAH TIKVA (dpa-AFX) - Teva Pharmaceutical Industries Ltd. (TEVA) reported the results of two studies, which demonstrated the efficacy of AJOVY or fremanezumab in migraine patients who also experience
Studies Show Effectiveness of AJOVY®▼ (fremanezumab) for Treatment of Migraine in Patients With Co-morbid Depression streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Teva Pharma (TEVA) AJOVY Effective in Migraine in Patients With Co-morbid Depression streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.
Age, female sex, headache intensity, pressure-like quality, the presence of photophobia or phonophobia, and worsening with physical activity were associated with persistent headache in a recent study.